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BACKGROUND: Caffeic acid inhibits osteoclastogenesis by downregulating expression of Cathepsin K and Nuclear Factor of Activated T 
cells (NFATc)1, as well as  inhibiting activity of Nuclear 
Factor kB (NFkB). Meanwhile TNF Receptor-associated 
Factor (TRAF)6 was not influenced by caffeic acid. In 
order to investigate further caffeic acid's mechanism in 
inhibiting osteoclastogenesis, regulation of caffeic acid 
on p38 Mitogen-activated Protein Kinase (MAPK) was 
investigated.
METHODS: RAW-D cells were pretreated with/without 
caffeic acid and treated with/without 20 ng/mL RANKL and 
1 ng/mL TNFα for 0.2, 1, 6, and 12 hour. Tartrate Resistant 
Acid Phosphatase (TRAP) staining was performed. Then, 
western blot analysis was performed to detect p38 MAPK 
and phosphorylated-p38 MAPK. Resulted protein bands 
were quantified and statistically analyzed.
RESULTS: Under induction of 20 ng/mL RANKL and 1 ng/
mL TNF-α, RAW-D cells were successfully differentiated 
into TRAP+ osteoclast-like polynuclear cells. Under 
treatment of 20 ng/mL of RANKL and 1 ng/mL of TNF-α 
for 0.2 or 1 hour, significant (p=0,000, T test) increment of 
phosphorylated  p38  MAPK  was  observed as compared 
with control. Pretreatment of 10 µg/mL caffeic acid 
significantly (p=0.000, T test) suppressed the 20 ng/mL of 
RANKL and 1 ng/mL of TNF-α-induced phosphorylation 
of p38 MAPK.
CONCLUSION: RANKL and TNF-α are potent 
osteoclastogenesis inductors in RAW-D cells, meanwhile 
caffeic acid could inhibit the RANKL and TNFα-induced 
osteoclastogenesis through p38 MAPK.
KEyWORDS: caffeic acid, osteoclastogenesis, RANKL, 
TNF-α, p38, MAPK, RAW-D cells
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Abstract
Introduction
Osteoclastogenesis, the development of osteoclast from 
precursor polynuclear cells (PNCs), could be induced 
by several factors, including Tumor Necrosis Factor 
(TNF) and Receptor Activator of Nuclear Factor kΒ 
(RANK) Ligand (RANKL).(1,2) The osteoclastogenesis 
related factors could be produced in the physiological 
development process (3), inflammatory process (3,4) and 
intraosseous tumor development process (5). After the 
binding of osteoclastogenesis ligands to their receptors, 
osteoclastogenesis signaling pathways were activated. The 
bindings of RANKL to RANK and TNF to TNF receptor 
(TNFR) can further lead to the activation of the Mitogen-
activated Protein Kinase (MAPK) family.(6,7) Among the 
MAPK family, p38 MAPK has been reported to play an 
important role in osteoclastogenesis.(8,9)
 Caffeic acid attracts much special attention because 
of its ability to protect the human from several diseases, 
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including cancer (10,11) and bone resorption (12-14). 
Caffeic acid induced osteosarcoma cells into apoptosis 
by activation of Caspases, including Caspase-8, -9 and 
-3.(10,11) Meanwhile in order to protect from bone 
resorption, caffeic acid targets osteoclastogenesis.(12-14) 
Caffeic acid did not induce apoptosis in PNCs (12), but 
it inhibited osteoclastogenesis by inhibiting expression 
of Cathepsin K and Nuclear Factor of Activated T cells 
(NFATc)1 (13), as well as  inhibiting activity of Nuclear 
Factor kB (NFkB) (12). However, caffeic acid did not 
target the expression of TNF Receptor-associated Factor 
(TRAF)6.(14) In order to investigate further caffeic acid's 
mechanism in inhibiting osteoclastogenesis, regulation of 
caffeic acid on p38 MAPK was investigated.
Methods
Cell Culture 
RAW-D cells were cultured in α-MEM (GIBCO-BRL, 
Grand Island, NY) with 10% FBS (Biosource, Camarillo, 
CA) at 37°C in a humidified incubator with 5% CO2. 
in vitro Osteoclastogenesis
Six thousand RAW-D cells were cultured in each well 
of a 96-well plate with the complete culture medium. 
Pretreatment of 10 µg/mL caffeic acid (Wako, Osaka, Japan) 
was conducted for 2 hours prior to the treatment of 20 ng/
mL RANKL (PeproTech, London, UK) and 1 ng/mL TNF-α 
(Roche Molecular Biochemicals, Mannheim, Germany). 
Three days later, Tartrate Resistant Acid Phosphatase 
(TRAP) staining using Leukocyte Acid Phosphatase Kit 
(Sigma-Aldrich, St. Louis, MO) was performed. TRAP+ 
PNCs were documented under an inverted microscope.
Western Blot
Treated cells were harvested and incubated with lysis buffer 
containing 10 mM Tris buffer (pH 7.4), 150 mM NaCl, 1% 
Triton-X100 and 100 μL protease inhibitor cocktail (Sigma-
Aldrich, St.Louis, MO). The proteins in the samples were 
separated by sodium dodecyl sulfate (SDS)-polyacrylamide 
gel electrophoresis and transferred to a nitrocellulose 
membrane (Biorad, Richmond, CA). After blocking with 
5% skim milk in phosphate buffer saline (PBS) (pH 7.4), 
the membrane were probed with 1:1000 diluted rabbit 
polyclonal anti-phospho-p38 MAPK (Thr180/Tyr182) 
antibody (Cell Signaling Technology, Danvers, MA). 
The secondary antibody was 1:2000 diluted horseradish 
peroxidase-conjugated donkey anti-rabbit antibody (Cell 
Signaling Technology). The bound antibodies were 
visualized using Immun Star HRP Chemiluminescent Kit 
(Bio-Rad Laboratories, Hercules, CA). Membrane was 
then stripped with Seppro stripping buffer (Sigma-Aldrich), 
blocked with 5 % skim milk in PBS, probed with rabbit 
polyclonal anti-p38 MAPK (Cell Signaling Technology), 
bound with same secondary antibody and visualized 
with the chemiluminescent kit. All visualized bands were 
captured using Alliance 4.7 (UVItech, Cambridge, UK) and 
quantified using UVIband software (UVItech). 
Statistical Analysis
Analyses were performed using IBM SPSS for Windows 
version 20.0 (IBM Corp., Armonk, NY). T-test was used to 
determine the statistical differences between the means of 
experiments. A probability value <0.05 was considered to 
be statistically significant. 
Results
Caffeic acid inhibited RANKL and TNFα-induced 
osteoclastogenesis in RAW-D Cells
Under induction of 20 ng/mL RANKL and 1 ng/mL TNFα, 
RAW-D cells were successfully differentiated into TRAP+ 
osteoclast-like PNCs (Figure 1B). However, by adding 10 
μg/mL caffeic acid prior to induction of 20 ng/mL RANKL 
Figure 1. Caffeic acid inhibited 
RANKL and TNF-α-induced 
osteoclastogenesis in RAW-D 
cells. A: Untreated RAW-D cells. 
B: RAW-D cells were treated with 
20 ng/mL of RANKL and 1 ng/mL 
of TNF-α. C: RAW-D cells were 
pretreated with 10 µg/mL caffeic 
acid and treated with 20 ng/mL of 
RANKL and 1 ng/mL of TNF-α. 
Bar: 100 µm.
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and 1 ng/mL TNFα, TRAP+ osteoclast-like PNC was not 
found (Figure  1C). 
Caffeic Acid inhibited RANKL and TNFα-induced 
Phosphorylation of p38 MAPK in RAW-D Cells
Under treatment of 20 ng/mL of RANKL and 1 ng/mL 
of TNF-α for 0.2 or 1 hour, significant (p=0,000, T test) 
increment of phosphorylated p38 MAPK was observed as 
compared with control (Figure 2). Treatment of 20 ng/mL 
of RANKL and 1 ng/mL of TNF-α for 6 and 12 hours did 
not induce phosphorylation of p38 MAPK. Pretreatment 
of 10 µg/mL caffeic acid significantly (p=0,000, T test) 
suppressed the 20 ng/mL of RANKL and 1 ng/mL of TNF-
α-induced phosphorylation of p38 MAPK.
Figure 2. Caffeic acid inhibited RANKL and TNF-
α-induced phosphorylation of p38 in RAW-D 
cells. RAW-D cells were pretreated with/without 10 
µg/mL caffeic acid and treated with/without 20 ng/
mL of RANKL and 1 ng/ml of TNF-α for 0, 0.2, 
1, 6 and 12 hours. Cells were lysed and subjected 
to immunoblotting assay using anti-p38 and anti-
phosphorylated p38 antibodies. Data represent a typical 
result from 3 independent experiments.
Discussion
Previous study has shown that caffeic acid did not 
significantly affect the expression of TRAF6 while 
significantly inhibited NFkB’s activity in RANKL and TNF-
α-induced TRAF6 transfected-RAW-D cells.(14) Despite 
TRAF6, the involvement of MAPK in the osteoclastogenesis 
signaling process induced by RANK-RANKL has been 
widely recognized.(6-9) MAPK is an enzyme that converts 
extracellular stimulus into various cellular responses. p38 
MAPK is a member of MAPK family that has an important 
role in tissue development and homeostasis functions 
such as cell differentiation, apoptosis, maturation, and 
cytokine production which initiates osteoclastogenesis.(8,9) 
After being activated, p38 MAPK will induce important 
transcription factors such as NFkB and NFATc1.(8,9,12) 
Inhibition of p38 MAPK was reported to fully diminish 
RANKL and TNF-α-induced osteoclast formation.(15) In 
the present study, RANKL and TNF-α induced formation 
of TRAP+ PNCs, meanwhile pretreatment of caffeic acid 
could diminish the formation of RANKL and TNF-α-
induced TRAP+ PNCs. The upregulated phosphorylation of 
p38 MAPK was clearly observed in RANKL and TNF-α-
induced RAW-D cell, meanwhile  pretreatment of caffeic 
acid   could   diminish   the   phosphorylation  of  p38 
MAPK. 
 RANKL and TNF-α which induce bone loss, can 
be secreted by activated T and B cells in inflammatory 
states.(16) Inhibition on RANKL and TNF-α-induced 
osteoclastogenesis by some agents has been reported, 
including osteoprotegerin (17), Simon extract (13) and its 
constituent, caffeic acid (10,12-14). However, mechanism 
of caffeic acid in inhibiting osteoclastogenesis remained 
unclear. Current study has shown that p38 MAPK is one of the 
second messengers that plays an important role in  RANKL 
and TNF-α-induced osteoclastogenesis. A schematic 
signaling pathway of RANKL-induced osteoclastogenesis 
in RAW-D cells can be seen in Figure 3. based on current 
results and previous report, caffeic acid is shown to inhibit 
activation of NFkB and p38 MAPK.  Further investigation 
for other activated second messengers should be pursued.
Conclusion
Taken together, current results suggested that RANKL and 
TNF-α are potent osteoclastogenesis inductors in RAW-D 
cells,  meanwhile  caffeic  acid could  inhibit  the RANKL 
and TNF-α-induced osteoclastogenesis through p38 
MAPK.
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Figure 3. Signaling pathway of RANKL-induced osteoclastogenesis in RAW-D cells.
